Double immunofluorescence analysis confirmed that CD45+ immune cells in S100a4−/− gliomas did not express S100A4, although S100A4 is expressed in a subset of glioma cells (Fig. 6f, Supplementary Fig. 9e). The gene discussed is S100A4; the disease is central nervous system cancer.